A Proof of Concept Study of the Effects of QAX576 (an Interleukin-13 Monoclonal Antibody) on Allergic Inflammation Following Out of Allergy Season Repeated Nasal Allergen Challenge in Subjects With Seasonal Allergic Rhinitis Sensitive to Timothy Grass Pollen
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Dectrekumab (Primary) ; Fluticasone propionate
- Indications Seasonal allergic rhinitis
- Focus Pharmacodynamics
- Sponsors Novartis
- 01 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
- 25 Jan 2008 New trial record.